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osting by EAbstract Gentamicin is an effective widely used antibiotic, but the risk of nephrotoxicity and oxi-
dative damage limit its long-term use. Hence, the current study aims to elucidate such hazardous
effects. To achieve the study aim male Wistar albino rats (Rattus norvegicus) were exposed to genta-
micin to investigate the resultant blood chemical changes and renal histological alterations. In
comparison with control rats, gentamicin produced outstanding tubular, glomerular and interstitial
alterations that included degeneration, necrosis, cytolysis and cortical tubular desquamation together
with mesangial hypercellularity, endothelial cell proliferation and blood capillary congestion. Com-
pared with control animals signiﬁcant blood chemical changes (P< 0.05) including free radicals,
ALT, AST, ALP, serum creatinine and serum urea were recorded in gentamicin-injected animals.
The ﬁndings revealed that exposure to gentamicin can induce signiﬁcant histological alterations in
the kidney as well as remarkable blood chemical changes that might indicate marked renal failure.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.epartment of Zoology, King
h 11451, Saudi Arabia. Tel.:
. Alariﬁ).
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lsevier1. Introduction
The kidney is a vital organ in health and disease. Many envi-
ronmental contaminants and chemical variables, including
drugs, alter the functions of the kidney (Mahmood and
Waters, 1994; Begg and Barclay, 1995).
Gentamicin (GM) is an effective aminoglycoside antibiotic
that is still widely used against serious and life-threatening
infections by Gram-positive and Gram-negative aerobic bacte-
ria, but nephrotoxicity and oxidative damage limits its long-
term clinical use (Whelton and Neu, 1982; Abdel-Naim
104 S. Alariﬁ et al.et al., 1999; Hansen et al., 2001; Al-Majed et al., 2002; Abo El-
Sooud, 2003; Ali et al., 2005; Dhanarajan et al., 2006; Ekor
et al., 2006; Kuhad et al., 2006; Nagai et al., 2006; Ali et al.,
2008; Priyamvada et al., 2008; Khan et al., 2009; Abdel-Rahe-
em et al., 2009; Ali et al., 2011). Gentamicin-induced nephro-
toxicity was reported in previous studies (Erdem et al., 2000;
Karahan et al., 2005; Buba et al., 2011; Chaware et al., 2011;
Kore et al., 2011; Sharma et al., 2011). Other studies have
shown that gentamicin also causes ototoxicity, skin rash, neu-
romuscular blockage, genotoxicity, hepatotoxicity, oxidative
damage, structural chromosomal aberrations and fragmenta-
tion (Mingeot-Leclercq and Tulkens, 1999; Chambers, 2001;
Schulze and Wollina, 2003; Yasin et al., 2003; Amici et al.,
2005; Parlakpinar et al., 2005; Sharifzadeh et al., 2005; Hong
et al., 2006; El-Ashmawy et al., 2006; AlKahtani et al., 2009;
Kandeel et al., 2011).
Studies on histological alterations in renal tissues due to
gentamicin are limited and have not been fully identiﬁed. With
this objective, a detailed histological study was undertaken
using the kidneys of Wistar albino rats killed at one-week
intervals up to four consecutive weeks after gentamicin treat-
ment. Additionally, blood chemical investigation was con-
ducted for more elucidation of the effect of tissue damage
which could be provoked by gentamicin.2. Materials and methods
All of the experimental procedures were conducted in the His-
tology and Cell Biology Lab., of the King Saud University,
Saudi Arabia, between 2010 and 2011.
Thirty-six male Wistar albino rats (Rattus norvegicus) of
the same age weighing 220–250 g were obtained from the
Animal House of King Saud University, Riyadh, Kingdom
of Saudi Arabia. Animals were randomly assigned to three
groups of 12 rats each and housed in metabolic cages. Fol-
lowing a period of stabilization (7 days), gentamicin in the
form of gentamicin sulfate (gentamicin injection, 40 mg/ml,
Sandoz, Switzerland) was administered intramuscularly.
Two groups of rats were injected daily with gentamicin at
respective doses of (80 mg/kg/day) and (150 mg/kg/day) for
four consecutive weeks. Control rats were only treated with
physiological saline. All treatments were given for four con-
secutive weeks and all rats were fed on a standard laboratory
animal diet pellet and water ad libitum and maintained under
controlled environmental conditions that included controlled
temperature (22 ± 1 C) and a normal photoperiod (12 h
dark and 12 h light).2.1. Blood chemistry
At the end of each week of the experimental period, blood
samples were taken from three rats from each group and serum
was separated for estimation of the various blood chemical
parameters such as free radicals, ALT, AST, ALP, creatinine
and urea. A blood chemical analyzer (Reﬂotron, Roche Co.,
Germany) was employed for this purpose using the speciﬁed
analysis kits supplied from analyzer’s manufacturer. For mea-
surement of free radicals in blood of the experimental animals,
FRAS-4 (Iram-Param Co., Italy) instrument was used and the
method d-RAM was applied.2.2. Histological study
Three rats from each group were sacriﬁced and the kidneys
were removed for histological examination. Fresh portions
of both kidneys from each rat were cut out rapidly, ﬁxed in
neutral buffered formalin (10%) and then dehydrated with
grades of ethanol (70%, 80%, 90%, 95% and 100%). Dehy-
dration was then followed by clearing the samples in two
changes of xylene. Tissue samples were then impregnated
with three changes of molten parafﬁn wax, then embedded
and blocked out. Tissue sections (4 lm) were stained accord-
ing to Bancroft and Stevens (1999) using the conventional
histological stains.
2.3. Statistical analysis
All data are presented as values means ± SD. The obtained
data were statistically analyzed by SAS (2002) using Duncan
test in order to comparison differences between the experimen-
tal groups at the level of P< 0.05 were considered signiﬁcant.3. Results
3.1. Blood chemistry
Table 1 and Fig. 1 show the results of blood chemistry inves-
tigation in all experimental groups. By the end of the ﬁrst week
of experimentation period, all gentamicin-injected animals in
G2 (150 mg/kg) died, hence the corresponding blood chemical
parameters were not recorded.
3.2. Gross examination
In the G1 (80 mg/kg) and G2 (150 mg/kg) groups, the kidneys
were moderately swollen and whitish spots on the cortex of
kidneys appeared in both of the gentamicin-treated groups
by the end of the ﬁrst week. However, these spots were heter-
ogeneously distributed at the end of the third and fourth weeks
of treatment compared with the control group (Figs. 2 and 3).
3.3. Histological alterations
Gentamicin-induced marked tubular, glomerular and intersti-
tial alterations in the kidneys of gentamicin-injected rats.
The following histological alterations were detected relative
to those of the control group.
3.3.1. Tubular alterations
Tubular alterations due to gentamicin treatment appeared
early in the form of necrosis, degeneration and vacuolization.
Tubular alterations in the kidney appeared by the end of the
ﬁrst week of gentamicin treatment and then increased in sever-
ity. These changes included degeneration up to severe necrosis,
which included most of the proximal convoluted tubules and
to a lesser extent the distal tubules (Fig. 4). The degenerative
tubules showed swelling, cytolysis, loss of the proximal tubular
brush border and tubular irregularity at 80 mg of gentamicin
after the second week of exposure, and became more promi-
nent thereafter.
Table 1 Blood chemistry parameters estimated at weekly intervals for all experimental groups.
Parameters Groups/weeks





















419 ± 00.00B 413 ± 00.00B 453 ± 0.00B 389 ± 00.00D 320 ± 00.00D* 199.33 ± 23.10C* 655 ± 0.0 * 557 ± 25.98B* 531.33 ± 31.75A*
ALT (ll/l)
M± SD
34.6 ± 1.56B 47 ± 00.00A 61.4 ± 0.00B 52.7 ± 4.85BC 47.03 ± 4.21A* 46.9 ± 3.98A 48.20 ± 8 0D* 47.43 ± 0.93C 45.47 ± 3.69A*
AST (ll/l)
M± SD
180.33 ± 21.36CB 143 ± 0.00C 182 ± 0.00C 224 ± 12.12B 296 ± 34.64A* 225.67 ± 42.15B* 200 ± 0.0 * 246 ± 17.58B 300.67 ± 47.08A*
Creatinine (mg/
dl) M± SD
0.5 ± 0.00D 0.50 ± 0.00B 0.5 ± 0.00A 0.50 ± 0.00A 0.83 ± 0.03D 1.92 ± 0.00B 0.50 ± 0.0 A 0.50 ± 0.00A 3.35 ± 0.37C*
Urea (mg/dl)
M± SD
37.63 ± 0.75D 35.10 ± 2.94B 44.70 ± 8.70C 49.53 ± 6.12A 89.73 ± 10.62C* 37.63 ± 0.75B 80.20 ± 0 0A* 55.17 ± 5.61A 295 ± 8.66A*
Free radicals (U
Carr) M± SD
365 ± 0.00A 296 ± 0.00A 123 ± 0.00B 322 ± 0.00B 360 ± 0.00A 151 ± 6.93C* 277 ± 0.0 * 379.67 ± 26.69A* 351.67 ± 47.08A
Different letter within the same row indicates signiﬁcant differences (p< 0.05) between experimental groups for the same blood chemica parameter.
ALP = alkaline phosphatase, ALT = alanine transaminase, AST = aspartate transaminase.
Compared with the control animals, the serum level of ALP was the highest at the 3rd week (655 ± 0.00), that of ALT peaked at 3rd wee (48.20 ± 8.70) and the highest level of AST serum level
was recorded at 1st week (296 ± 34.64).
Regarding creatinine and urea blood levels, the highest level of creatinine was recorded at 2nd week (1.92 ± 0.00) while that of urea wa at 1st week (89.73 ± 10.62).
























































Figure 1 Level of free radicals in the different experimental
groups at weekly intervals. At weeks 3 and 4 the level of free
radicals was signiﬁcantly higher in G1 (80 mg/kg) compared with
the control group. The level of free radicals in animals of G1 was
increased markedly by elapsing time after gentamicin intoxication.
The highest level of free radicals (379.67 ± 26.69 U Carr) was
recorded in G1 at the 4th week.
Figure 2 Morphological appearance of kidney of control rat.
Figure 3 Morphological appearance of kidney of treated rat
showing whitish spots on surface of the kidney and in the outer
zone of the cortex.
Figure 4 Photomicrographs showing severe necrosis and scat-
tered hemorrhages (150 mg gentamicin/kg/day) at the end of the
ﬁrst week. H&E 400·.
Figure 5 Photomicrographs showing severe necrosis with cellu-
lar debris accumulation in the tubular lumen (80 mg gentamicin/
kg/day) at the end of the second week. H&E 400·.
Figure 6 Photomicrographs showing tubular necrosis and lym-
phocytes inﬁltration (80 mg gentamicin/kg/day) at the end of the
second week. H&E 400·.
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age than the medulla, and renal tubules became more affected
and showed excessive accumulation of luminal debris (Fig. 5).
Figure 7 Photomicrographs showing calciﬁcation of the necrotic
tubules (80 mg gentamicin/kg/day) at the end of the third week.
H&E 400·.
Figure 8 Photomicrographs showing tubular dilatation with
tubular necrosis (80 mg gentamicin/kg/day) at the end of the
second week. H&E 400·.
Figure 9 Photomicrographs showing accumulation of eosino-
philic material in the collecting tubules. H&E 400·.
Figure 10 Photomicrographs showing accumulation of eosino-
philic material in the convoluted tubules. H&E 400·.
Figure 11 Photomicrographs showing mesangial glomerular
hypercellularity and lymphocytes inﬁltration (80 mg gentamicin/
kg/day) at the end of the second week. H&E 1000·.
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tubular lymphocyte inﬁltration appeared after two weeks of
gentamicin treatment at 80 mg (Fig. 6). Calciﬁcation of the
necrotic renal tubules appeared at the end of the third week
of treatment (Fig. 7).
Many tubules exhibited dilation after one week of gentami-
cin treatment, which then increased in severity (Fig. 8). This
alteration appeared ﬁrst in the inner edge of the cortex and
then progressed into the remaining part of the cortex. Some
of the dilated collecting tubules in both the cortex and medulla
contained dense eosinophilic casts (Figs. 9 and 10).
3.3.2. Glomerular alterations
Alterations in the glomeruli of gentamicin-treated rats ap-
peared from the ﬁrst week of treatment in the form of mesangial
hypercellularity and glomerular endothelial cell proliferation.
An increase in the number and volume of mesangial cells
appeared in the glomeruli of rats that received 80 mg of genta-
micin and more for at least one week. This change increased in
severity with an increase in gentamicin dose and period of expo-sure, and became prominent at the fourth week of treatment
(Fig. 11).
Figure 12 Photomicrographs showing hemorrhagic foci with
tubular necrosis (80 mg gentamicin/kg/day) at the end of the third
week. H&E 400·.
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The kidneys of gentamicin-treated rats showed cortical inter-
stitial edema with dilatation and congestion of intertubular
blood capillaries. The intertubular spaces of gentamicin-trea-
ted rats became widely separated from one another due to
the accumulation of edematous ﬂuid. Additionally, the kidneys
of gentamicin-treated rats showed congestion after the ﬁrst
week of treatment and exhibited intertubular blood capillary
dilation. Hemorrhagic foci accompanied tubular necrosis after
two weeks of gentamicin treatment (Fig. 12).
The loop of Henle showed very little or no alterations due
to gentamicin, the control group showed no signiﬁcant histo-
logical changes during the experimental period.
Rats of the 150-mg group died at the end of the ﬁrst week of
treatment showed severe tubular degenerative and necrotic
changes over extensive areas.4. Discussion
Gentamicin is known to generate reactive oxygen species asso-
ciated with an increase in lipid peroxidation and decrease in
antioxidant enzyme activity in the kidney (Banday et al.,
2008). Additionally, it acts as an iron chelator by forming an
iron–gentamicin complex that is a potent catalyst of radical
generation (Khan et al., 2009).
Various blood chemical parameters were estimated for the
present experimental animals, these involved the enzymes
employed for evaluation of the organ functions. In the present
study there was signiﬁcant (P< 0.05) increase in the blood
levels of ALT, AST and ALP. The blood levels of ALT,
AST and ALP are indicative of the functional efﬁciency of li-
ver and kidney. The level of these enzymes is very sensitive to
any disease conditions of such organs (Tietz, 1996). Blood level
of creatinine and urea were also estimated since these two
parameters are of special signiﬁcance to evaluate renal func-
tion (Smith et al., 1988; Frank, 1993; Tietz, 1996). The level
of free radicals in the blood of the present experimental ani-
mals was also assessed to reveal the existence of any oxidative
stress (Sener et al., 2002; Ali et al., 2005; Eslami et al., 2011).
The observed renal histological changes and the accompanyingincreased level of ALP indicate the compromised renal func-
tion. The study of Kadkhodaee et al. (2005) showed gentami-
cin-induced renal toxicity and signiﬁcant increase in the level
of ALP. The recorded increased level of ALT indicates func-
tional disorders of the liver, kidney and heart as postulated
by Mayne (1994). The presently observed necrobiotic changes
of the renal tubules conﬁrm the concept that signiﬁcant struc-
tural changes of the kidney led to signiﬁcant increase in the
blood level of ALT (Smith et al., 1988).
The presently recorded increased blood level of AST also
supports the conclusion that gentamicin-induced renal damage
is directly related to such increment. Increased blood level of
AST is usually coincided with renal damage (Stryer, 1988).
Creatinine is considered as one of the most reliable indica-
tors of the efﬁciency of renal function (Travlos et al., 1996;
Kore et al., 2011; Babu et al., 2011). Increased blood creatinine
is strongly related with renal damage (Soliman et al., 2007;
Kore et al., 2011). The presently recorded signiﬁcant increase
in blood creatinine was associated with distinct renal structural
damage (Chaware et al., 2011; Eslami et al., 2011). As revealed
by histological examination, 150-mg group showed renal dam-
age as early as the ﬁrst week of gentamicin injection while the
80-mg group showed remarkable renal damage by the end of
the last week. Abdel-Naim et al. (1999) and Karahan et al.
(2005) found that kidney function test had been affected after
5–7 days of gentamicin injection. Both gentamicin-injected
groups in the present study showed signiﬁcant increase of
blood urea. Nephrotoxicity, as demonstrated in the present
cases, is associated with increased urea in blood (Karahan
et al., 2005; El-Ashmawy et al., 2006; Soliman et al., 2007; Zee-
ni et al., 2007; Chaware et al., 2011; Babu et al., 2011). Pres-
ently free radicals were signiﬁcantly increased in the blood of
gentamicin-injected animals. Increased rate of free radicals’
production contributes to induction of nephrotoxicity (Sener,
2002; Eslami et al., 2011). Reactive oxygen metabolites, such
as superoxide anions and hydroxyl radicals, were supposed
to be one of the main contributors of gentamicin-induced
nephrotoxicity (Parlakpinar et al., 2003; Ali et al., 2005; Kad-
khodaee et al., 2005) through lipid peroxidation (Kumer et al.,
2000; Abdel-Raheem et al., 2010). Free radicals released from
mitochondria of renal tubular cells were found to be the main
factor in induction of gentamicin-induced nephrotoxicity
(Kumer et al., 2000; Al-Majed et al., 2002; Abdel-Raheem
et al., 2010). Severe and extensive histological alterations in
the renal tissue induced by gentamicin as seen in the present
work suggest the potential of gentamicin to cause oxidative
damage to macromolecules and cellular organelles.
The ﬁndings of the present investigation showed that expo-
sure to gentamicin resulted in progressive tubular, glomerular
and interstitial histological alterations.
The tubular necrosis and degenerative changes seen in the
present work conform with the ﬁndings of previous investiga-
tions (Can et al., 2000; Kumer et al., 2000; Al-Majed et al.,
2002; Ekor et al., 2006; Nitha and Janardhanan, 2008; Kalay-
arasan et al., 2009; Saleemi et al., 2009; Ali et al., 2011; Deh-
ghani et al., 2011).
The results of the present work showed that the cortex of
the kidney was more affected than the medulla as a result of
long-term treatment with gentamicin. This might indicate that
a relatively higher concentration of gentamicin reaches the cor-
tex via the bloodstream than that entering the medulla. This is
in agreement with the ﬁndings of Houghton et al. (1976) and
Blood chemical changes and renal histological alterations induced by gentamicin in rats 109Karahan et al. (2005) which showed that most of the gentami-
cin accumulates in the renal cortex.
The results of the present work showed that tubular dam-
age was more prominent in proximal convoluted tubules than
distal tubules. Other investigators have reported similar ﬁnd-
ings (Mingeot-Leclercq and Tulkens, 1999). This could be
due to the fact that proximal convoluted tubules are the pri-
mary sites of reabsorption and active transport, thus leading
to a higher concentration of gentamicin in the epithelial lining
of these tubules. This might also suggest that gentamicin tox-
icity is related to its accumulation in the proximal tubules.
The death of all rats of the 150-mg group after one week of
treatment might indicate that a dose of 150 mg/kg body weight
for seven consecutive days causes dramatic nephrotoxicity in
rats. A previous study showed that a dose of 100 mg/kg body
weight for six days resulted in signiﬁcant nephrotoxicity in rats
(Cuzzocrea et al., 2002; Dehghani et al., 2011).5. Conclusion
The ﬁndings of this study indicate that exposure to gentamicin
is capable of inducing adverse signiﬁcant blood chemical
changes and marked renal histological harmful alterations in
Rattus norvegicus. The present result may contribute to better
understanding of the gentamicin-induced nephrotoxicity in hu-
man, and also may be considered as an experimental base of
the relevant human studies.Acknowledgment
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